Every 424B that Rezolve AI PLC (RZLV) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow RZLV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RZLV filings page.
Rezolve AI plc is offering 62,500,000 ordinary shares at $4.00 per share to institutional investors, for gross proceeds of $250,000,000. After paying $12,500,000 in placement agent fees and other estimated costs, the company expects net proceeds of about $237,000,000.
The cash will be used to accelerate investment in its sales organization, pursue potential accretive M&A opportunities, and for general corporate and working capital purposes. Ordinary shares outstanding were 336,327,587 as of January 13, 2026, and are expected to rise to 398,827,587 after this offering, so new investors will face immediate dilution. The shares trade on Nasdaq under the symbol “RZLV.”
Rezolve AI plc filed Prospectus Supplement No. 2 updating its previously registered mixed shelf. It continues to cover up to 7,499,994 Ordinary Shares for issuance upon exercise of Public Warrants at $11.50 per share, and up to 164,775,654 Ordinary Shares for resale by selling holders, as described in the prospectus.
The supplement updates the selling securityholders table, including the sale by Sir David Wright of 250,000 Ordinary Shares to DBLP Sea Cow Limited and the sale of 150,000 Ordinary Shares by Anthony Sharp. Resale amounts remain as previously registered and may be sold from time to time. Examples of registered resale allocations include DBLP Sea Cow Limited 26,915,689 and J.V.B. Financial Group, LLC 5,027,508. The Ordinary Shares and Public Warrants trade on Nasdaq as RZLV and RZLVW, respectively.
Rezolve AI plc filed a Rule 424(b)(3) prospectus to register the resale, from time to time, of up to 37,000,000 Ordinary Shares by selling security holders connected to its PIPE financing. Rezolve will not receive any proceeds from sales by these holders.
The registered shares were issued or are issuable under the September 2025 PIPE at $5.40 per share; the financing closed on September 25, 2025 with aggregate gross proceeds of approximately $200 million to the company at that time. The registered amount represents about 11.5% of outstanding Ordinary Shares as of the prospectus date. The Ordinary Shares trade on Nasdaq as “RZLV,” which closed at $3.85 on November 6, 2025.
The company notes that sales, or the market’s perception of potential sales, of this substantial block could increase volatility or pressure the trading price. The selling holders may have acquired shares at prices below current market levels. Distribution methods may vary as described under “Plan of Distribution.”
Rezolve AI plc filed a prospectus supplement updating a previously registered mixed offering: up to 7,499,994 Ordinary Shares for issuance upon exercise of Public Warrants at $11.50 per share, and up to 164,925,654 Ordinary Shares for resale by selling holders.
The update revises the selling securityholders table, including the sale by DBLP Sea Cow Limited of 10,600,000 Ordinary Shares as disclosed on an October 10, 2025 Schedule 13D/A. The Ordinary Shares and Public Warrants trade on Nasdaq as RZLV and RZLVW, respectively.